TABLE 2.
Inhibitor | HIV-1 LAI/CEM-SS
|
HIV-1 IIIB/MT-4
|
||
---|---|---|---|---|
IC50 (μM) | CC50 (μM) | IC50 (μM) | CC50 (μM) | |
SP1 | 39 | 64 | >CC50 | 30 |
SP2 | 3 | 7 | >CC50 | 3 |
SP3 | 3 | 11 | >CC50 | 3 |
SP4 | 5 | 9 | >CC50 | 5 |
SP5 | 10 | 20 | >CC50 | 8 |
SP7 | 6 | 7.5 | >CC50 | 43 |
SP9 | 3 | 6 | >CC50 | 5 |
SP10 | 40 | 48 | >CC50 | 29 |
SP12 | 5 | 7 | >CC50 | 6 |
SP15 | 0.3 | 9 | >CC50 | 3 |
AZTa | 0.004 | 0.01 |
AZT, zidovudine.